Prostate-specific membrane antigen (PSMA) is a tumor-associated antigen overexpressed in prostate adenocarcinoma cells, regardless of androgen status, in the neovasculature of solid tumors, and has a low expression in benign and extra-prostatic tissues [4,5]. Here, FOLH1 is linked to prostate adenocarcinoma.